Teacher Retirement System of Texas grew its position in CVS Health Corp (NYSE:CVS) by 24.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 830,569 shares of the pharmacy operator’s stock after purchasing an additional 160,938 shares during the period. Teacher Retirement System of Texas’ holdings in CVS Health were worth $67,542,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Fieldpoint Private Securities LLC increased its position in CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,000 shares during the last quarter. Arcadia Investment Management Corp MI boosted its stake in shares of CVS Health by 119.6% during the 3rd quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares in the last quarter. MPS Loria Financial Planners LLC bought a new stake in shares of CVS Health during the 2nd quarter worth about $119,000. Gemmer Asset Management LLC boosted its stake in shares of CVS Health by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares in the last quarter. Finally, Captrust Financial Advisors bought a new stake in shares of CVS Health during the 2nd quarter worth about $155,000. 81.69% of the stock is currently owned by institutional investors.

In related news, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.61% of the stock is owned by corporate insiders.

Several research firms have recently issued reports on CVS. Vetr downgraded CVS Health from a “hold” rating to a “sell” rating and set a $76.66 price target for the company. in a research note on Tuesday. Royal Bank of Canada began coverage on CVS Health in a research note on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target for the company. ValuEngine downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Robert W. Baird reiterated a “hold” rating and set a $77.00 price target on shares of CVS Health in a research note on Friday, October 27th. Finally, Mizuho set a $90.00 price target on CVS Health and gave the stock a “buy” rating in a research note on Tuesday, October 24th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. CVS Health currently has a consensus rating of “Buy” and an average price target of $86.63.

Shares of CVS Health Corp (NYSE CVS) opened at $79.44 on Wednesday. CVS Health Corp has a 52 week low of $66.45 and a 52 week high of $84.72. The firm has a market capitalization of $80,470.00, a P/E ratio of 16.41, a P/E/G ratio of 1.25 and a beta of 0.90. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05.

CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. During the same quarter in the prior year, the company earned $1.64 EPS. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. equities analysts forecast that CVS Health Corp will post 5.89 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.52%. CVS Health’s payout ratio is 41.32%.

TRADEMARK VIOLATION NOTICE: This article was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2018/01/17/teacher-retirement-system-of-texas-raises-holdings-in-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related stocks with our FREE daily email newsletter.